<DOC>
	<DOCNO>NCT00914797</DOCNO>
	<brief_summary>The purpose study assess blood urine concentration terbutaline evaluate difference inhale oral terbutaline order distinguish treatment terbutaline dope terbutaline dope control .</brief_summary>
	<brief_title>Terbutaline Concentrations Blood Urine</brief_title>
	<detailed_description>To investigate serum urine concentration terbutaline evaluate difference inhale terbutaline ( 2 mg ) oral terbutaline ( 10 mg ) order distinguish dope terbutaline anti-asthmatic treatment terbutaline . To investigate mention three group : healthy men , male asthmatic subject male elite athlete asthma .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Terbutaline</mesh_term>
	<criteria>Physiciandiagnosed asthma positive reversibility challenge test . Informed consent . Age 18 45 year . Sex : male . Asthma classify mild moderate accord GINA guideline . Used beta2agonist minimum 12 month . Smokers exsmokers smoke history 10 pack year . Respiratory tract infection within last 2 week prior visit 1 2 . Subjects chronic disease asthma allergy . Allergy towards study medicine . Use beta2agonist 6 day prior study day .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Doping</keyword>
	<keyword>Beta agonist</keyword>
	<keyword>Terbutaline</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>